Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

470 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Amyloid-PET and 18F-FDG-PET in the diagnostic investigation of Alzheimer's disease and other dementias.
Chételat G, Arbizu J, Barthel H, Garibotto V, Law I, Morbelli S, van de Giessen E, Agosta F, Barkhof F, Brooks DJ, Carrillo MC, Dubois B, Fjell AM, Frisoni GB, Hansson O, Herholz K, Hutton BF, Jack CR Jr, Lammertsma AA, Landau SM, Minoshima S, Nobili F, Nordberg A, Ossenkoppele R, Oyen WJG, Perani D, Rabinovici GD, Scheltens P, Villemagne VL, Zetterberg H, Drzezga A. Chételat G, et al. Among authors: minoshima s. Lancet Neurol. 2020 Nov;19(11):951-962. doi: 10.1016/S1474-4422(20)30314-8. Lancet Neurol. 2020. PMID: 33098804 Review.
Multimodal imaging in Alzheimer's disease: validity and usefulness for early detection.
Teipel S, Drzezga A, Grothe MJ, Barthel H, Chételat G, Schuff N, Skudlarski P, Cavedo E, Frisoni GB, Hoffmann W, Thyrian JR, Fox C, Minoshima S, Sabri O, Fellgiebel A. Teipel S, et al. Among authors: minoshima s. Lancet Neurol. 2015 Oct;14(10):1037-53. doi: 10.1016/S1474-4422(15)00093-9. Epub 2015 Aug 26. Lancet Neurol. 2015. PMID: 26318837 Review.
The need of standardization and of large clinical studies in an emerging indication of [18F]FDG PET: the autoimmune encephalitis.
Morbelli S, Arbizu J, Booij J, Chen MK, Chetelat G, Cross DJ, Djekidel M, Drzezga A, Ekmekcioglu O, Garibotto V, Hesse S, Ishii K, Jafari L, Lammertsma AA, Law I, Mathews D, Minoshima S, Mosci K, Pagani M, Pappata S, Silverman DH, Signore A, Van De Giessen E, Villemagne V, Barthel H; European Association of Nuclear Medicine (EANM) and of the Society of Nuclear Medicine and Molecular Imaging (SNMMI). Morbelli S, et al. Among authors: minoshima s. Eur J Nucl Med Mol Imaging. 2017 Mar;44(3):353-357. doi: 10.1007/s00259-016-3589-9. Epub 2016 Dec 6. Eur J Nucl Med Mol Imaging. 2017. PMID: 27924371 No abstract available.
Toward a Universal Readout for 18F-Labeled Amyloid Tracers: The CAPTAINs Study.
Bischof GN, Bartenstein P, Barthel H, van Berckel B, Doré V, van Eimeren T, Foster N, Hammes J, Lammertsma AA, Minoshima S, Rowe C, Sabri O, Seibyl J, Van Laere K, Vandenberghe R, Villemagne V, Yakushev I, Drzezga A. Bischof GN, et al. Among authors: minoshima s. J Nucl Med. 2021 Jul 1;62(7):999-1005. doi: 10.2967/jnumed.120.250290. Epub 2021 Mar 12. J Nucl Med. 2021. PMID: 33712532 Free article.
EANM procedure guidelines for PET brain imaging using [18F]FDG, version 2.
Varrone A, Asenbaum S, Vander Borght T, Booij J, Nobili F, Någren K, Darcourt J, Kapucu OL, Tatsch K, Bartenstein P, Van Laere K; European Association of Nuclear Medicine Neuroimaging Committee. Varrone A, et al. Eur J Nucl Med Mol Imaging. 2009 Dec;36(12):2103-10. doi: 10.1007/s00259-009-1264-0. Eur J Nucl Med Mol Imaging. 2009. PMID: 19838705
Appropriate use criteria for amyloid PET: a report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's Association.
Johnson KA, Minoshima S, Bohnen NI, Donohoe KJ, Foster NL, Herscovitch P, Karlawish JH, Rowe CC, Carrillo MC, Hartley DM, Hedrick S, Pappas V, Thies WH. Johnson KA, et al. Among authors: minoshima s. J Nucl Med. 2013 Mar;54(3):476-90. doi: 10.2967/jnumed.113.120618. Epub 2013 Jan 28. J Nucl Med. 2013. PMID: 23359661 Free article. Review.
470 results